Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$14.2 - $23.8 $15,549 - $26,061
-1,095 Reduced 0.79%
136,874 $2.6 Million
Q2 2020

Aug 14, 2020

SELL
$12.18 - $29.0 $236,218 - $562,426
-19,394 Reduced 12.32%
137,969 $3.64 Million
Q1 2020

May 15, 2020

SELL
$9.94 - $54.8 $4.59 Million - $25.3 Million
-462,060 Reduced 74.6%
157,363 $2.12 Million
Q4 2019

Feb 14, 2020

BUY
$29.6 - $49.4 $69,619 - $116,188
2,352 Added 0.38%
619,423 $28.4 Million
Q3 2019

Nov 14, 2019

SELL
$39.2 - $63.2 $7.18 Million - $11.6 Million
-183,281 Reduced 22.9%
617,071 $24.4 Million
Q2 2019

Aug 14, 2019

BUY
$60.4 - $84.2 $48.3 Million - $67.4 Million
800,352 New
800,352 $0

About Motus GI Holdings, Inc.


  • Ticker MOTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 2,996,840
  • Description
  • Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
More about MOTS
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.